Sangamo Therapeutics, Inc. · NASDAQ:SGMO

Dubois-Stringfellow Nathalie had 4,036 Sangamo Therapeutics, Inc. shares withheld for tax (Form 4)

Traded May 25, 2026 · Filed May 27, 2026

On May 25, 2026, Dubois-Stringfellow Nathalie (SVP-CHIEF DEVELOPMENT OFFICER) had 4,036 Sangamo Therapeutics, Inc. shares withheld for tax at US$0.17 for US$686, leaving 328,733 shares. Filed May 27, 2026 (Form 4).

Withheld for tax
4,036 shares
Price
US$0.17
Value
US$686
Holding after
328,733 shares
Trading plan
No
Role
SVP-CHIEF DEVELOPMENT OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 25, 2026Common StockShares withheld for tax4,036US$0.17328,733Direct

Source

View original at SEC

Related